Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent

Despite global vaccination programs, infections with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) continue to cause severe disease with significant morbidity and mortality. Severe coronavirus disease 2019 (COVID-19) is characterized by an exuberant inflammatory response in the lung l...

Descripción completa

Detalles Bibliográficos
Autores principales: Declercq, Jozefien, De Leeuw, Elisabeth, Lambrecht, Bart N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170572/
https://www.ncbi.nlm.nih.gov/pubmed/35709568
http://dx.doi.org/10.1016/j.cyto.2022.155934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170572/
https://www.ncbi.nlm.nih.gov/pubmed/35709568
http://dx.doi.org/10.1016/j.cyto.2022.155934

Ejemplares similares